GlaxoSmithKline Plc Divests Two Of Its Travel Vaccines

  • Oct 21, 2019 BST
  • Team Kalkine
  • GlaxoSmithKline Plc (GSK) has divested two of its travel vaccines to Bavarian Nordic.
  • The company’s divested two travel vaccines include Rabipur for the prevention of rabies and Encepur for the prevention of tick-borne encephalitis.
  • The company will receive an upfront payment of around EUR301 million or £259 million and milestone payments for a total consideration of up to EUR955 million or £822million, with the said divestment.
  • On 21st October 2019, at the time of writing, GMT 11:45 AM, GSK shares were trading at GBX 1,625.20, down by 21.00 points or 1.28 per cent against the previous day closing price.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK